The U.S. Supreme Court turned away an appeal made by rebuffed efforts made by Bristol Myers Squibb Co’s (NYSE: BMY) Juno Therapeutics Inc to reinstate a $1.2 billion award it won in its patent f...
Tag: Bristol
GILD And BMY Offer A Haven In A Turbulent Market
Following another ugly market week, the average U.S. stock is now trading in Bear Market territory. Of course, such was also the case in 2020 and 2018 and 2016 and more than a few other periods throug...
Calif. Pharmaceutical Companies AbbVie And Bristol Myers Lay Off 360—Here Are The Major U.S. Layoffs This Summer
California pharmaceutical companies AbbVie and Bristol Myers Squibb reportedly plan to cut 360 employees—becoming the latest U.S. companies to reassess their headcounts as employers fear the economy c...
3 Stocks That Could Benefit From Powell Channeling Volcker
WASHINGTON – MAY 14: Former Federal Reserve Chairman Paul Volcker testifies before the Joint … [+] Economic Committee May 14, 2008 on Capitol Hill in Washington, DC. The full committee met...
TPTX Stock Doubles On Bristol Myers’ $4.1 Billion All-Cash Takeover
Turning Point Therapeutics (TPTX) snagged a $4.1 billion offer from Bristol Myers Squibb (BMY) on Friday, and TPTX stock more than doubled. X The deal adds repotrectinib to Bristol Myers’ wheelh...
Turning Point Stock Doubles on Bristol Deal. What It Means for Biotech M&A.
Text size Photograph by Georges Gobet/AFP/Getty Images Turning Point Therapeutics stock has more than doubled after Bristol Myers Squibb announced that it had agreed to buy the company. It’s just the ...
BMY Stock: Bristol Expects $10.5 Billion Shortfall This Year As Generics Loom
Bristol Myers Squibb (BMY) offered better-than-expected sales guidance Friday, and BMY stock rose despite looming competition for two of its biggest cancer drugs. X Revlimid and Abraxane are among Bri...